X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (73) 73
Patent (14) 14
Publication (13) 13
Conference Proceeding (9) 9
Book / eBook (2) 2
Dissertation (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
index medicus (33) 33
male (25) 25
middle aged (24) 24
female (21) 21
aged (19) 19
hematology (19) 19
adult (17) 17
performing operations (14) 14
transporting (14) 14
vehicle suspension arrangements (14) 14
vehicles in general (14) 14
life sciences (12) 12
oncology (11) 11
abridged index medicus (9) 9
multiple myeloma - drug therapy (9) 9
aged, 80 and over (8) 8
analysis (8) 8
bortezomib (8) 8
therapy (8) 8
treatment outcome (8) 8
cancer (7) 7
chemotherapy (7) 7
retrospective studies (7) 7
dose-response relationship, drug (6) 6
multiple myeloma (6) 6
multiple myeloma - mortality (6) 6
survival (6) 6
survival analysis (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
engineering sciences (5) 5
multiple myeloma - pathology (5) 5
prognosis (5) 5
robotics (5) 5
automatic (4) 4
dexamethasone - administration & dosage (4) 4
lenalidomide (4) 4
lipoprotein - blood (4) 4
physics (4) 4
studies (4) 4
trial (4) 4
adolescent (3) 3
animals (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - therapeutic use (3) 3
apolipoproteins a - blood (3) 3
automatic control engineering (3) 3
boronic acids - administration & dosage (3) 3
care and treatment (3) 3
cholesterol (3) 3
classification (3) 3
cohort studies (3) 3
computer science (3) 3
cross-sectional studies (3) 3
dexamethasone - adverse effects (3) 3
drug therapy (3) 3
efficacy (3) 3
environmental sciences (3) 3
hematology, oncology and palliative medicine (3) 3
history (3) 3
imatinib mesylate (3) 3
leukemia (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3) 3
melphalan (3) 3
melphalan - administration & dosage (3) 3
mice (3) 3
mobile robotics (3) 3
multiple myeloma - diagnosis (3) 3
multiple myeloma - therapy (3) 3
multivariate analysis (3) 3
mutation (3) 3
neoplasms (3) 3
path tracking (3) 3
peripheral vascular disease (3) 3
prospective studies (3) 3
pyrazines - administration & dosage (3) 3
robots (3) 3
sciences of the universe (3) 3
stabilization (3) 3
stem cell transplantation (3) 3
stem cells (3) 3
thalidomide (3) 3
thalidomide - administration & dosage (3) 3
thalidomide - adverse effects (3) 3
time factors (3) 3
translocation, genetic (3) 3
transplantation (3) 3
transplantation, autologous (3) 3
vehicles (3) 3
young adult (3) 3
africa - ethnology (2) 2
african continental ancestry group (2) 2
age factors (2) 2
aged patients (2) 2
agricultural vehicles (2) 2
agriculture (2) 2
alcohol drinking - blood (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 30, pp. 4621 - 4629
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 22, pp. 3664 - 3670
Journal Article
Blood, ISSN 0006-4971, 05/2016, Volume 127, Issue 21, pp. 2569 - 2574
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 25, pp. 2941 - 2948
Journal Article
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10192, pp. 29 - 38
Journal Article
Blood Cancer Journal, ISSN 2044-5385, 08/2018, Volume 8, Issue 8, pp. 74 - 13
From a liquid biopsy, cell-free DNA (cfDNA) can provide information regarding basal tumoral genetic patterns and changes upon treatment. In a prospective... 
CLASSIFICATION | ONCOLOGY | HEMATOLOGY | SOMATIC MUTATIONS | PET/CT | Metabolism | Biopsy | Mutation | Index Medicus | Life Sciences | Cancer
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2019, Volume 25, Issue 14, pp. 4224 - 4230
Purpose: Carfilzomib is a novel generation proteasome inhibitor. The Carmysap trial demonstrated that twice-weekly KMP (carfilzomib, melphalan, prednisone)... 
THERAPY | BORTEZOMIB | EFFICACY | ONCOLOGY | SAFETY | ELDERLY-PATIENTS
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 22, pp. 5752 - 5758
Journal Article
BLOOD, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, p. 3028
Conference: 57th Annual Meeting of the American-Society-of-Hematology - Orlando, FL - DEC 05-08, 2015 
HEMATOLOGY | Life Sciences
Conference Proceeding
Journal of Nephrology, ISSN 1121-8428, 4/2018, Volume 31, Issue 2, pp. 317 - 320
Chronic lymphocytic leukemia (CLL) may induce renal complications, which are becoming increasingly common, but in this context the occurrence of minimal change... 
Nephrology | Minimal change disease | Medicine & Public Health | Hematology | B lymphocytosis | Chrnic lynmphocytic leukemia | Nephrotic syndrome | Urology | DIAGNOSIS | GLOMERULAR-DISEASES | UROLOGY & NEPHROLOGY | LEUKEMIA | CANCER | CHEMOTHERAPY
Journal Article
Clinical Case Reports, ISSN 2050-0904, 06/2019, Volume 7, Issue 6, pp. 1171 - 1177
Multi‐organ AL amyloidosis is a therapeutic challenge because of light chain deposits severely damaging the function of concerned organs. Cardiac involvement,... 
light chain myeloma | cardiac involvement | daratumumab | multi‐organ amyloidosis | chemotherapy | Proteins | Immunoglobulins | Hematology | Biopsy | Medical prognosis | Blood tests | Multiple myeloma | Bone marrow | Histology | Patients
Journal Article
Journal Article